Oncological outcomes of minimally invasive surgery in non-endometrioid endometrial Cancer patients with varying prognostic risks: a retrospective cohort study based on the ESGO/ESTRO/ESP 2020 guidelines

Table 2 Oncologic outcomes of patients

Variable	MIS	Open	P-value
	(n = 31)	(n = 68)
Recurrences total, %			0.007
Yes	10(32.25%)	7(10.24%)
No	21(67.74%)	61(89.71%)
Recurrences site,%
Vaginal	1(3.23%)	1(1.47%)	0.846
Pelvis	0(0%)	1(1.47%)	0.685
Lymph node	2(6.45%)	3(4.41%)	0.948
Distant metastasis	7(22.58%)	2(2.94%)	0.006
Recurrences by different prognostic risks,%
Intermediate-risk	0(0%)	2(2.94%)	0.846
High-risk	10(32.25%)	5(7.35%)	0.001
Median follow-up, months	61.30	65.95

ISSN: 1471-2482